Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of programmed death-ligand 1 (PD-L1) positivity on clinical and molecular features of patients with metastatic gastric cancer.

Cancer medicine - 1 Sept 2023

Shin Minkyue, Ahn Soomin, Jung Jaeyun, Hyung Sujin, Kim Kyoung-Mee, Kim Seung Tae, Kang Won Ki, Lee Jeeyun

Abstract excerpt

BACKGROUND: Programmed death-ligand 1 (PD-L1) is an important screening biomarker to select patients with gastric cancer (GC) for optimized treatment, including immune checkpoint inhibitors (ICI). METHODS: In this single-institution retrospective cohort study, patients with metastatic GC with available PD-L1 results between October 2019 and September 2021 were identified by reviewing their electronic medical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to B7-H1 Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Epstein-Barr Virus Infections

Share to Immune Checkpoint Inhibitors

Share to Microsatellite Instability

Share to Prognosis

Share to Stomach Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 37654198
DOI: 10.1002/cam4.6472
PMCID: PMC10557860

Genes

GC
DOT1L
IRS2
LRP1B
MDC1
MET
PIK3CA
PTPRT
TET2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of programmed death-ligand 1 (PD-L1) positivity on clinical and molecular features of patients with metastatic gastric cancer.PMID 37654198Read ↗

High PD-L1 expression in gastric cancer (GC) patients and correlation with molecular featuresSemantic proximity Read ↗

Clinical Significance of Tumor and Immune Cell PD-L1 Expression in Gastric AdenocarcinomaSemantic proximity Read ↗

Mutations Defining Patient Cohorts With Elevated PD-L1 Expression in Gastric CancerSemantic proximity Read ↗

Distinct genomic landscapes of gastroesophageal adenocarcinoma depending on PD-L1 expression identify mutations in RAS-MAPK pathway and TP53 as potential predictors of immunotherapy efficacy.Semantic proximity Read ↗

Profiles of PD-1, PD-L1, PD-L2 in Gastric Cancer and Their Relation with Mutation, Immune Infiltration, and Survival.Semantic proximity Read ↗

Immunohistochemical‐Based Molecular Typing of ACRG Combined With Immune‐Associated PD ‐ L1 Expression Can Predict the Prognosis of Gastric CancerSemantic proximity Read ↗

Clinicopathological features of Epstein-Barr virus infection, microsatellite instability, tumor mutation burden and PD-L1 status in Chinese patients with gastric cancerSemantic proximity Read ↗

Polymorphism of the programmed death‐ligand 1 gene is associated with its protein expression and prognosis in gastric cancerSemantic proximity Read ↗

M1-like TAMs are required for the efficacy of PD-L1/PD-1 blockades in gastric cancerSemantic proximity Read ↗

Clinicopathological Features of Epstein-Barr Virus Infection, Microsatellite Instability, Tumor Mutation Burden and PD-L1 Status in Chinese Patients with Gastric CancerSemantic proximity Read ↗

Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancerSemantic proximity Read ↗

Real-World Genomic Landscape of Korean Gastric Cancer: Integrating Biomarker Associations and Clinical Outcomes in Metastatic Gastric Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.